8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 8, 2021 (July 7, 2021)

HEALTHCARE TRUST OF AMERICA, INC.

HEALTHCARE TRUST OF AMERICA HOLDINGS, LP

(Exact name of registrant as specified in its charter)

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

On July 7, 2021, Healthcare Trust of America, Inc. (the "Company"), held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company's stockholders approved the Healthcare Trust of America, Inc. Amended and Restated 2006 Incentive Plan (the "Plan"), which had previously been adopted by the Company's Board of Directors subject to stockholder approval. A total of 10,000,000 shares of common stock are reserved for grant under the Plan.

The description of the Plan, included as Appendix A to the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 30, 2021, is incorporated herein by reference.

On July 7, 2021, the Company held its Annual Meeting for the purpose of acting on the following four proposals properly brought before the meeting:

(1) the election of seven director nominees listed below, each to hold office until the 2022 Annual Meeting and until his or her successor is duly elected and qualifies;

(2) to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers;

(3) the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021; and

(4) to approve the Company’s Amended and Restated 2006 Incentive Plan.

Election of Directors

At the Annual Meeting, the Company’s stockholders elected all the director nominees identified below to serve until the Annual Meeting in 2022 and until their successors are duly elected and qualified. Set forth below are the final voting tallies from the Annual Meeting relating to such election of director nominees:

* Note that % of “Votes For” excludes abstentions and broker non-votes, consistent with the Company’s charter.

Advisory Vote to Approve the Compensation of our Named Executive Officers

At the Annual Meeting, the Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. Set forth below are the final voting tallies from the Annual Meeting relating to such advisory vote to approve the compensation of the Company’s named executive officers:

* Note that % of “Votes For” excludes abstentions and broker non-votes, consistent with the Company’s charter.

Ratification of Auditors

At the Annual Meeting, the Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021. Set forth below are the final voting tallies from the Annual Meeting relating to such auditor ratification:

* Note that % of “Votes For” excludes abstentions and broker non-votes, consistent with the Company’s charter.

Approval of the Amended and Restated 2006 Incentive Plan

At the Annual Meeting, the Company’s stockholders approved the Company’s Amended and Restated 2006 Incentive Plan. Set forth below are the final voting tallies from the Annual Meeting relating to such approval of the Company’s Amended and Restated 2006 Incentive Plan:

* Note that % of “Votes For” excludes broker non-votes. Abstentions are included as votes against.

(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned hereunto duly authorized.